Drug factory · FDA FEI 3002808385

Taro Pharmaceutical Industries Ltd.

14 Hakitor Street, Haifa Bay, Israel

What it does, for whom

FDA inspection history

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Jul 11, 2019 inspection

• Extent of discrepancy, failure investigations 21 CFR 211.192
  Investigations of an unexplained discrepancy and a failure of a batch or any of its components to meet any of its specifications did not extend to other batches of the same drug product.

Registered with FDA for: analysis; api manufacture; label; manufacture; pack.